Health Mar 30

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. Photo by Andrew Kelly/REUTERS
FDA panel narrowly rejects experimental ALS drug

Wednesday's vote by the Food and Drug Administration expert panel is a potential setback for patient groups who have lobbied for the medication's approval for ALS for more than a year.